Single-Dose Safety Study of APD791 in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy

In brief

The APD791-001 study is designed primarily to evaluate the safety and tolerability of APD791 when administered as a single oral dose to healthy adult subjects.

Key facts

Study ID

NCT00529646

Run by

Arena Pharmaceuticals

People needed

90

Starts

2007-07-01

Last updated by the study team

2008-12-30

Who can join

Age: 19 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adult men and women, ages 19-45
• Non smokers

You may not qualify if…

• History of a bleeding disorder
• Recently donated blood or had significant blood loss
• Current use of a prescription medication
• Pregnant females

Where it is running

• MDS Pharma Services — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.